glp-1 agonist cardiovascular outcomes in major trials with receptor agonists Real-World Evidence for GLP-1 Receptor
Description
Because bones adapt to the weight they carry, losing weight means less stress on the skeleton, and over time this can lead to small decreases in bone strength
For more information read our Terms & Conditions
While initial effects at 3 months were minimal, sustained reductions at later time points suggest a potentially durable effect on BMI (Figure 2)
Brain Inj 2019;33:734-819
For a 5 mg/mL concentration: add 2 mL of water
64 In contrast with prior anti-obesity medications, concerns about suicide intention have not been confirmed for GLP-1 RA therapy
